Bisacolax

Quick links to important sections

Bisacolax

Method of action: Laxative

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bisacolax

Quick Facts

Property Description
Active ingredient Bisacodyl
Form Enteric-coated tablet, Suppository
Pharmacological class Stimulant Laxative / Contact Cathartic
Common purpose Relief from occasional constipation
Origin Synthetic (Diphenylmethane derivative)

Bisacolax is a medicinal preparation whose active ingredient is Bisacodyl, designed to provide active relief from occasional constipation. It is strictly categorized as a stimulant laxative, functioning to restore temporary regularity in the lower gastrointestinal tract.

Defining Bisacolax: Substance and Pharmacological Class

Bisacolax contains Bisacodyl, a synthetic substance classified chemically as a diphenylmethane derivative. The compound is officially categorized as a stimulant laxative, which is recognized for its direct interaction with the intestinal lining. This mode of action is identified as effective for actively initiating bowel movement, distinguishing it from bulk-forming or osmotic agents.

Bisacodyl is frequently utilized as an over-the-counter (OTC) option, offering readily accessible relief for adults experiencing temporary sluggishness or infrequent stool passage.

Composition, Forms, and General Purpose

Bisacolax is a single-ingredient product (monopreparation) containing only Bisacodyl alongside inert pharmaceutical excipients. The preparation is commonly administered via the oral route as an enteric-coated tablet or the rectal route as a suppository. The enteric coating is an essential design feature, protecting the Bisacodyl from stomach acid and ensuring its release only in the colon, its intended site of action, which is crucial for its reliable function as a stimulant laxative. The medicine's overall purpose is to promote and facilitate predictable bowel evacuation by increasing both localized intestinal muscle contractions (peristalsis) and fluid secretion. The substance is utilized for its efficacy in achieving bowel clearance.

Regulatory References

  1. WHO Essential Medicines List for Bisacodyl

What side effects are possible with Bisacolax?

Possible Side Effects and Safety Information for Bisacolax

The safety profile of Bisacolax (Bisacodyl) is structured around potential adverse reactions documented in official regulatory sources. Side effects are classified by how often they may occur and the body system affected.

Documented Adverse Reactions

Side effects are categorized by frequency (Common, Uncommon, Rare) based on clinical data:

Frequency Side Effects (Key Examples)
Common Abdominal pain, abdominal cramps, diarrhea, nausea.
Uncommon Dizziness, vomiting, abdominal discomfort, anorectal discomfort, haematochezia (blood in stool).
Rare Anaphylactic reactions, angioedema, syncope (fainting), colitis (including ischaemic colitis), dehydration.

Most reported adverse reactions involve Gastrointestinal disorders. Rare events, such as anaphylactic reactions and colitis, are classified as serious adverse reactions that require immediate attention.

Safety Considerations and Restrictions

Official labeling defines specific safety constraints and risks, including:

  • Risks of Excessive Use: Prolonged or excessive daily use is restricted, as it can lead to fluid and electrolyte imbalance, specifically low potassium levels (hypokalaemia), and potentially chronic diarrhea.
  • Contraindications: Bisacolax should not be used in cases of severe dehydration, intestinal obstruction (ileus), acute abdominal conditions (e.g., appendicitis), or severe abdominal pain accompanied by nausea and vomiting.
  • Specific Populations: Caution is advised regarding use in patients with conditions that may be aggravated by fluid loss, such as those with renal insufficiency or elderly patients. Use during pregnancy or lactation should only be initiated after consulting a healthcare professional.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile of Bisacodyl overdose primarily documents the consequences of excessive gastrointestinal stimulation and resulting fluid loss. Acute overdose is characterized by severe diarrhea (watery stools), intense abdominal cramps or pain, nausea, and vomiting. These manifestations result in a clinically significant loss of fluid and electrolytes, such as potassium.

Required Emergency Action

If an overdose is suspected, official guidance mandates to seek medical help or contact a Poison Control Center right away. The most serious potential outcomes are secondary to severe electrolyte imbalance and dehydration, which can potentially lead to cardiac arrhythmias or seizures.

Management and Risks

Regulatory documents indicate that no specific antidote is known. Management is defined as symptomatic and supportive, focusing immediately on the replacement of fluids and correction of electrolyte imbalance. Patients with underlying conditions, such as renal insufficiency, and patient groups including the elderly and young, are at higher risk of harm from overdose-induced dehydration. For chronic overdose or abuse, long-term complications such as renal tubular damage and persistent hypokalaemia are documented. The medication must be immediately discontinued upon evidence of harmful dehydration.

Therapeutic Uses of Bisacolax

What Bisacolax Treats: Main Uses and Benefits

Bisacolax is commonly used to help with symptoms related to functional constipation, and is used for managing symptoms related to infrequent stool passage, straining, and difficulty defecating. The medication is generally considered relevant for situations ranging from occasional, transient episodes of irregularity to the supportive therapeutic management of persistent, chronic constipation. This use generally provides support that helps ease the overall symptom burden and contributes to improved day-to-day comfort during periods of colonic sluggishness.

The medication is commonly used to help with symptomatic relief of occasional constipation and to assist with bowel clearance before certain medical procedures. This is a procedural application relevant when preparation is needed to help the digestive tract achieve appropriate clearance before certain diagnostic procedures or surgery. This use contributes to ensuring the conditions are met for accurate medical examinations and supports the necessary preparation for subsequent interventions.


Quick Fact: Relief for Functional Constipation
Core Benefit: Supports the patient during episodes of heightened discomfort and difficulty defecating.
Clinical Contexts: Applied for short-term assistance with irregularity and pre-procedural preparation.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Bisacolax?

The official eligibility profile for Bisacolax (Bisacodyl) is strictly defined by regulatory documents, listing populations for whom use is prohibited or restricted based on age and existing health status.


Absolute Contraindications

Bisacolax must not be used by individuals with absolute contraindications, which include pre-existing serious gastrointestinal conditions such as ileus, intestinal obstruction, bowel perforation, toxic megacolon, or acute abdominal conditions (e.g., appendicitis). Use is also prohibited in cases of severe dehydration or known hypersensitivity to Bisacodyl or its components.


Age-Related and Conditional Restrictions

Adults are the standard eligible population. Use is not recommended for general purposes in children under 12 years without advice from a healthcare professional. Oral tablets are specifically not recommended for children under 6 years. For persistent constipation in children under 10 years, treatment must proceed only under the guidance of a physician.

In pregnancy and lactation, eligibility is highly conditional and restricted; the medicine should be used only if clearly needed and following medical advice. Additionally, Bisacolax suppositories must be avoided if anal fissures or ulcerative proctitis are present.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Bisacolax (Bisacodyl) primarily through two mechanisms: effects on the drug's formulation integrity and pharmacodynamic reinforcement.

Documented Interaction Patterns

Category Interacting Substances / Outcome Interaction Type Restriction
Formulation Integrity Antacids, Milk, H2 Blockers, or Proton Pump Inhibitors (PPIs). Physicochemical Mandatory timing separation.
Pharmacodynamic Risk Diuretics or Adrenocorticosteroids. Additive effect. Risk of increased hypokalemia.

Required Timing Separation

Co-administration with substances that reduce acidity in the upper gastrointestinal tract, such as antacids and milk or milk products, is documented to cause the premature dissolution of the enteric coating on Bisacolax tablets. This unintended release leads to gastric irritation. To prevent this physicochemical interaction, the oral tablet must not be taken within one hour of consuming these substances or other acidity-reducing medicines, including PPIs and H2 blockers.

Additive Electrolyte Risk

When co-administered with certain medications, there is a documented pharmacodynamic interaction involving electrolyte balance. The concurrent use of Bisacolax with diuretics or adrenocorticosteroids may produce an additive risk of hypokalemia (low potassium levels). This resulting electrolyte imbalance may subsequently increase a patient’s sensitivity to cardiac glycosides. Regulatory notes highlight that the risk associated with fluid and electrolyte loss is more pronounced in dehydrated and elderly patient populations.

Mechanism of Action

How Bisacolax Works

Bisacolax acts locally within the colon following its conversion to the active metabolite, bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM), primarily mediated by intestinal deacetylase and bacterial enzymes.

BHPM exerts a dual action on the colonic physiology. First, the active metabolite interacts with sensory nerve endings in the colonic mucosa, causing direct stimulation of enteric neurons. This activation modulates the intrinsic motor activity of the colon, which results in the generation of high-amplitude propagated contractions (HAPCs) and an acceleration of colonic transit.

Second, BHPM modulates fluid transport across the colonic epithelium. It is an agonist of adenylate cyclase, leading to an increase in intracellular cyclic AMP (cAMP) levels within enterocytes. Elevated cAMP promotes the active secretion of chloride and bicarbonate ions into the lumen, followed by the passive efflux of sodium, potassium, and water due to osmotic gradients. Additionally, Bisacolax acts as a negative modulator of Aquaporin-3, further reducing water reabsorption from the lumen. The combination of increased motility and enhanced intraluminal fluid accumulation modulates the consistency and movement of colonic contents.

Dosage and Administration Information

Administration Methods

Bisacolax is available in different oral and rectal formulations. The method of administration depends on the specific form of the medication being used.

Oral Tablets

Oral tablets are typically taken with a full glass of water. They are designed with a special coating to ensure the medication reaches the intestines before dissolving. To maintain the integrity of this coating, tablets are swallowed whole rather than crushed, chewed, or broken. It is also standard practice to avoid taking these tablets within one hour of consuming antacids, milk, or dairy products, as these substances can cause the coating to dissolve prematurely.

Rectal Suppositories

Suppositories are intended for rectal use only. Before administration, the protective wrapper is removed. The individual typically lies on their side with one knee drawn toward the chest to facilitate insertion. The suppository is inserted pointed-end first and pushed high enough into the rectum so that it does not slide out. Remaining in a reclined position for a short period after insertion helps the medication stay in place as it melts.

Rectal Enemas

Enemas are provided in pre-filled containers for rectal administration. The tip of the applicator is lubricated and carefully inserted into the rectum while the individual is lying down. The contents are delivered by squeezing the container steadily. Once the liquid has been administered, the applicator is removed, and the individual should remain in position until they feel the urge to evacuate, which usually occurs shortly after application.

Recent Clinical Evidence

Bisacolax: Recent Clinical Evidence

Early-Phase Clinical Trials

Research has explored the compound's activity in clinical settings. Initial studies investigated the compound in human subjects, primarily focusing on establishing the Maximum Tolerated Dose (MTD) and observing preliminary responses in small patient cohorts (n=50 and n=110, respectively).

Key Findings from Phase 3 Studies

The pivotal phase 3 clinical trials, including Study A (n=800) and Study B (n=1,200), examined the drug’s association with changes in various clinical measures over 6-month and 12-month periods.

  • Study A (6 Months): This study evaluated the drug in adult subjects meeting specific diagnostic criteria. The primary focus was on changes in the Disease Activity Score (DAS) from baseline. Research specifically examined whether the drug was associated with changes in joint function in patients with severe symptoms.
  • Secondary Outcomes: Furthermore, Study A evaluated whether the compound was associated with reduced pain and limited inflammation. A 12-month extension in Study B reported that subjects receiving the drug demonstrated an observed reduction in measures of disease activity.

Safety and Tolerability

Studies related to the drug’s safety profile have reported common adverse events, including temporary nausea and mild headache. Safety studies reviewed the drug's use in specific groups, including patient groups with mild cardiovascular risks. Research also investigated whether administration alongside physiotherapy influenced outcomes, and studies reported on outcomes in subjects with a history of liver disease.


This information describes the outcomes reported in clinical studies. Always consult with a healthcare professional for personal medical advice, diagnosis, and treatment.

Frequently Asked Questions (FAQ)

Common questions about Bisacolax (FAQ)

Q: Is Bisacolax the same as other laxatives I can buy over the counter?

Official information states that Bisacolax is classified as a stimulant laxative, which means it works by actively promoting intestinal movement. This mode of action is distinct from other types of over-the-counter laxatives, such as bulk-forming agents, which add volume to the stool, or stool softeners, which work by adding water to the stool.

Q: Is Bisacolax commonly used before medical procedures like a colonoscopy?

Regulatory documents indicate that the medicine is used for bowel evacuation prior to medical examinations such as surgery, endoscopy, or X-rays. In these cases, it is typically used as part of a preparation regimen under specific professional guidance.

Q: How long can a person usually use Bisacolax before regulatory warnings advise stopping?

Regulatory guidance advises that Bisacolax should generally be used for temporary relief, often for no more than five to seven days. This restriction is in place because frequent or extended use may increase the risk of dependence or cause the bowels to lose their normal activity.

Q: If I feel nauseous after taking Bisacolax, is that a common side effect?

Official data classifies nausea as a Common side effect. Official safety information also cautions that gastric irritation and vomiting can occur if the enteric coating of the tablet is damaged by chewing it or by taking it too close in time to antacids or milk products.

Q: What is the difference between Bisacolax and a stool softener?

Bisacolax is a stimulant laxative that actively increases muscle contractions in the colon to push contents through and increases fluid secretion. A stool softener belongs to a different class of medicine that works primarily by allowing water and fat to mix with the stool, making it easier to pass.

Q: Why do some people report dependency with medicines like Bisacolax?

Official guidance notes that prolonged or excessive daily use of stimulant laxatives may lead to the physiological loss of normal bowel function, which is described as dependence. The body may begin to rely on the external stimulus provided by the medicine to initiate a bowel movement.

Q: Is Bisacolax used for all types of constipation?

No, official labeling indicates the medicine for the relief of occasional constipation and irregularity. The medicine is not generally intended for the management of chronic constipation.

Q: Can Bisacolax be taken while breastfeeding, according to regulatory data?

Regulatory documents state that if a person is breastfeeding, they should ask a health professional before use. Use during lactation is often considered conditional and requires professional medical advice.

Q: What if Bisacolax doesn't work for me after the recommended initial time frame?

Official information advises that if the desired laxative effect fails to occur, or if the medicine is needed for more than one week, use should be stopped. At that point, consultation with a health professional is advised in regulatory notes.

Q: Does Bisacolax come in different strengths?

Yes, the medicine is available in different strengths depending on its form. For example, it is commonly available as 5 mg oral tablets and 10 mg rectal suppositories.

Q: Can Bisacolax be used by elderly people?

Regulatory documentation advises that caution should be used when this medicine is administered to the elderly patient population, who are noted to be associated with an increased risk of fluid and electrolyte imbalances or dehydration.

Q: Why is proper hydration mentioned in connection with using Bisacolax?

Proper hydration is mentioned because the drug's mechanism involves increasing fluid secretion into the colon. Prolonged or excessive use can potentially lead to dehydration and loss of electrolytes, which is a documented, rare adverse event.

Q: Is there any research looking into the long-term use of Bisacolax?

Clinical trials providing strong evidence for daily use generally cover treatment periods of up to four weeks. Research for use in certain chronic conditions has extended to 6 or 12 months, but continuous long-term use is not typically supported by initial labeling.

Q: What are the most commonly reported side effects of Bisacolax in studies?

Studies classify the most commonly reported adverse events as primarily gastrointestinal disorders. These include abdominal cramps, abdominal pain, and diarrhea, which are generally categorized as Common (affecting up to 1 in 10 users).

Q: Can people with kidney problems use Bisacolax?

Official information advises caution for patients with conditions like renal insufficiency (impaired kidney function). This population is typically managed under medical guidance.

Q: Can Bisacolax affect the way my body absorbs nutrients?

Regulatory notes state that the chronic use of this medicine may potentially reduce the body's ability to absorb certain fat-soluble vitamins (A, D, E, and K) and certain minerals, such as calcium.

Q: Is Bisacolax available as a generic medicine?

Yes, the compound's active ingredient, Bisacodyl, is a generic, non-branded over-the-counter medicine. It is widely available under various brand names and as its generic form.

Q: What does it mean if Bisacolax is described as an 'enteric-coated' tablet?

The enteric coating is a protective layer that ensures the tablet remains protected from stomach acid and is released only in the colon. This is crucial for the medicine to work as intended and helps prevent irritation or discomfort in the stomach.

Q: Are there known interactions between Bisacolax and certain vitamins or supplements?

Yes, there are documented concerns that chronic or excessive use may interact with the absorption of certain multivitamins and minerals. Specifically, this is noted for the fat-soluble vitamins (A, D, E, K) and calcium.

Q: Does Bisacolax affect blood pressure?

The medicine is not labeled to directly affect blood pressure. However, its use can cause fluid and electrolyte depletion, which may lead to symptoms like dizziness or faintness related to changes in blood pressure upon standing, particularly when used alongside certain diuretics.

Q: Can Bisacolax be used by people with a history of digestive blockages?

The medicine is an absolute contraindication and must not be used in cases of existing intestinal obstruction (ileus). Any person with a history of such conditions is advised to consult a health professional before considering use, as the product is contraindicated for existing intestinal obstruction.

Q: How does the time of day I take Bisacolax impact the expected effect?

The time of day is related to the drug's onset of action. Oral tablets are often recommended to be taken at night because they typically require 6 to 12 hours to produce a bowel movement. Suppositories, which work much faster (15 to 60 minutes), are often used when a quick effect is needed, such as in the morning.

Q: Are headaches a known potential side effect of Bisacolax?

Yes, mild headache has been reported as an adverse event in some clinical safety studies. However, official information does not consistently categorize it among the most Common (affecting 1 in 10 people) side effects.

Q: Is Bisacolax considered safe for children?

Official labeling restricts use based on age. Tablets are not generally recommended for children under 12 years for general use, and use in children under 6 years is restricted and typically managed under the guidance of a health professional.

Q: Why do some people experience gas or bloating while using Bisacolax?

While the official adverse reaction table focuses on cramps and diarrhea, symptoms like bloating and flatulence (gas) are commonly reported side effects across various classes of laxative medicines.

Q: How is the effect of Bisacolax different from natural bowel movements?

The medicine's effect differs because it works by directly stimulating the nerves and muscle walls of the colon to accelerate movement (peristalsis) and actively increase water content. Natural bowel movements are generally passive, resulting from diet and natural digestive activity.

Q: What level of evidence exists for Bisacolax's effectiveness?

The effectiveness for its indicated purpose of occasional constipation is supported by multiple controlled clinical trials, including Phase 3 studies. This research provides moderate certainty evidence for short-term use.

Q: What is the official recommended storage condition for Bisacolax?

Official documentation requires the product to be stored at controlled room temperature, typically between 20 C and 25 C (68 F and 77 F). It must be kept in the original container and protected from excessive heat and moisture.

Q: Is the term 'cathartic' sometimes used to describe the action of Bisacolax?

Yes, official drug information classifies the medicine not only as a stimulant laxative but also as a contact cathartic. This term is used to describe its strong and predictable effect on promoting evacuation.

How should Bisacolax be stored and disposed of?

Storage and Disposal Requirements

The storage and disposal instructions for bisacodyl are governed by official regulatory standards to maintain product stability and safety. The product must be stored at controlled room temperature, typically between 20 C and 25 C (68 F and 77 F), with temporary excursions permitted up to 30 C.

Environmental and Container Rules

  • Protection: The medicine must be protected from excessive heat and moisture and stored in a dry place.
  • Packaging: It is required to store the product in the original container. Do not use the medicine if the individual blister unit is open or torn.
  • Child Safety: The container must be kept strictly out of reach of children.

Disposal of Unused Product

Any unused or expired product and related waste material must be disposed of in accordance with local requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bisacolax found in:

A-Z Index: